![Edward Michael](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Michael
Director/Board Member at
QUIDELORTHO CORPORATION
Net worth: 383 218 $ as of 31/05/2026
Profile
Edward L.
Michael is currently Director at NeuMoDx Molecular, Inc., PhysIQ, Inc., Protenus, Inc., and Gilda's Club.
Mr. Michael serves as Independent Director at QuidelOrtho Corp.
since 2018.
Mr. Michael is Managing Partner at LionBird Ventures Ltd. since 2012.
Mr. Michael is Executive Partner at Tyree & D’Angelo Partners Management LP.
Former roles include Independent Director at Quidel Corp., Director at Staffly, Inc. and Telesofia Medical Ltd. Mr. Michael was Executive Vice President-Diagnostic Products at Abbott Laboratories from 2011 to 2013.
Mr. Michael was Senior Vice President-Medical Products at Abbott Molecular, Inc., Abbott Spine, Inc., and Abbott Animal Health, Inc. Mr. Michael was Vice President-Immunoassay & Clinical Chemistry at Abbott Diagnostics, Inc. Education includes undergraduate studies at Indiana University and graduate studies at Indiana University Maurer School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/06/2026 | 29,433 ( 0.04% ) | 383 218 $ | 31/05/2026 |
Edward Michael active positions
| Companies | Position | Start |
|---|---|---|
| QUIDELORTHO CORPORATION | Director/Board Member | 01/01/2018 |
LionBird Ventures Ltd.
 LionBird Ventures Ltd. Investment ManagersFinance LionBird Ventures invests in companies located in the United States and Israel. The firm targets companies operating in the fields of digital healthcare and other industries such as ecommerce, enterprise-solutions, mobile & software applications and fintech. It provides financing for pre-seed, seed, seed- extension and early stage capital requirements with investment ranging from USD 0.5 - 2 million and acts as a lead investor and makes co-investments. It participates in follow on investments. | Private Equity Investor | 01/07/2012 |
Protenus, Inc.
 Protenus, Inc. Packaged SoftwareTechnology Services Develops healthcare compliance analytics platform for hospitals and pharmacies operations | Director/Board Member | - |
NeuMoDx Molecular, Inc.
 NeuMoDx Molecular, Inc. Medical SpecialtiesHealth Technology Operates as a diagnostic company | Director/Board Member | - |
PhysIQ, Inc.
 PhysIQ, Inc. Packaged SoftwareTechnology Services Provides proprietary predictive analytics for human physiology | Director/Board Member | - |
Gilda's Club | Director/Board Member | - |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Private Equity Investor | - |
Former positions of Edward Michael
| Companies | Position | End |
|---|---|---|
Abbott Spine, Inc.
 Abbott Spine, Inc. Medical SpecialtiesHealth Technology Develops spinal implant technologies | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Edward Michael
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
Abbott Molecular, Inc.
 Abbott Molecular, Inc. Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and medical products | Health Technology |
NeuMoDx Molecular, Inc.
NeuMoDx Molecular, Inc. Medical SpecialtiesHealth Technology Operates as a diagnostic company | Health Technology |
PhysIQ, Inc.
PhysIQ, Inc. Packaged SoftwareTechnology Services Provides proprietary predictive analytics for human physiology | Technology Services |
Protenus, Inc.
Protenus, Inc. Packaged SoftwareTechnology Services Develops healthcare compliance analytics platform for hospitals and pharmacies operations | Technology Services |
Staffly, Inc.
 Staffly, Inc. Data Processing ServicesTechnology Services Provides a retailers platform service | Technology Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott Spine, Inc.
Abbott Spine, Inc. Medical SpecialtiesHealth Technology Develops spinal implant technologies | Health Technology |
Gilda's Club | |
Abbott Diagnostics, Inc.
 Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells medical diagnostic instrument, test and automation products | Health Technology |
Abbott Animal Health, Inc.
 Abbott Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
LionBird Ventures Ltd.
LionBird Ventures Ltd. Investment ManagersFinance LionBird Ventures invests in companies located in the United States and Israel. The firm targets companies operating in the fields of digital healthcare and other industries such as ecommerce, enterprise-solutions, mobile & software applications and fintech. It provides financing for pre-seed, seed, seed- extension and early stage capital requirements with investment ranging from USD 0.5 - 2 million and acts as a lead investor and makes co-investments. It participates in follow on investments. | Finance |
Tyree & D’Angelo Partners Management LP
Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Finance |
Indiana University Maurer School of Law
 Indiana University Maurer School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telesofia Medical Ltd.
 Telesofia Medical Ltd. Medical/Nursing ServicesHealth Services Provides a healthcare platform | Health Services |
QuidelOrtho Corp.
 QuidelOrtho Corp. Medical SpecialtiesHealth Technology Manufactures in vitro diagnostics products | Health Technology |
- Stock Market
- Insiders
- Edward Michael
